Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.
SWAN Genomics has raised $317K in total funding. The most recent round was Grant. The last funding was announced in March 2026.
SWAN Genomics's investors include Investible, Pacific Channel, Proto Axiom, NSW Government, Australian Economic Accelerator.
SWAN Genomics is headquartered in Sydney, Australia.
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.
SWAN Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SWAN Genomics — Funding & Investors." VCBacked, March 6, 2026, https://www.vcbacked.co/company/swan-genomics. Accessed November 15, 2026.
VCBacked. (2026). SWAN Genomics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/swan-genomics
{{cite web |title=SWAN Genomics — Funding & Investors |url=https://www.vcbacked.co/company/swan-genomics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at SWAN Genomics? Request a listing update